Department Of Public Health 8
351. Associations between serum levels of brain-derived neurotrophic factor, corticotropin releasing hormone and mental distress in vitiligo patients
352. Prevalence and mortality of infective endocarditis in Kazakhstan: A nationwide epidemiological study (2018–2022)
353. Prevalence of Anxiety, Depression, and Insomnia Among Medical Workers in Emergency Medical Services in Eastern Kazakhstan
354. Prevalence of Anxiety, Depression, and Insomnia Among Medical Workers in Emergency Medical Services in Eastern Kazakhstan
355. Risk of Infective Endocarditis Following Invasive Dental Procedures: A Systematic Review and Meta-Analysis
356. Trends of ciprofloxacin use in Kazakhstan, impacts of COVID-19, and strategies for AMR control
357. Socio-behavioral determinants of early vs. long-term HIV infection in Kazakhstan: roles of self-testing, alcohol, drug use and sexual networks
358. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
359. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
360. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
361. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
362. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
363. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
364. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
365. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
366. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
367. Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021
368. A global action agenda for turning the tide on fatty liver disease
369. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
370. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
371. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
372. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
373. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
374. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
375. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
376. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
377. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
378. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
379. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
380. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
381. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
382. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
383. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
384. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
385. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
386. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
387. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
388. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
389. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
390. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
391. Empowering Climate Resilience: Leveraging Cloud Computing and Big Data for Community Climate Change Impact Service (C3IS)
392. The prevalence of depression in patients with lumbar degenerative disk disease: A systematic review and meta-analysis
393. CRISPR revolution: Unleashing precision pathogen detection to safeguard public health and food safety
394. Smart technology for public health: reshaping the future of food safety
395. Adaptation of the Health Literacy Survey Questionnaire (HLS19-Q) for Russian-Speaking Populations—International Collaboration across Germany, Israel, Kazakhstan, Russia, and the USA
396. Circulating microRNAs demonstrate limited diagnostic potential for diabetic retinopathy in the population of Kazakhstan
397. ITGA2 Gene Polymorphism Is Associated with Type 2 Diabetes Mellitus in the Kazakhstan Population
398. Data Resource Profile: The Global Health and Population Project on Access to Care for Cardiometabolic Diseases (HPACC)
399. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
400. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
1 6 7 8 9 10 15